Impact statement
-
From 2016 to 2022, 51.5% of children aged 4–5 years and 74.5% of children and adolescents aged 6–17 years received treatment in line with pediatric ADHD clinical practice guidelines, although adherence declined over time.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Data availability
Y.Z. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Data sharing will be available from Y.Z. upon a reasonable request.
References
Li, Y. et al. Prevalence and trends in diagnosed ADHD among US children and adolescents, 2017-2022. JAMA Netw. Open 6, e2336872 (2023).
Wolraich, M. et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 28, 1007–1022 (2011).
Wolraich, M. L. et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 144, e20192528 (2019). Subcommittee on children and adolescents with attention-deficit/hyperactive disorder.
Bannett, Y., Gardner, R. M., Posada, J., Huffman, L. C. & Feldman, H. M. Rate of pediatrician recommendations for behavioral treatment for preschoolers with attention-deficit/hyperactivity disorder diagnosis or related symptoms. JAMA Pediatr. 176, 92–94 (2022).
US Census Bureau. NSCH Datasets, accessed 28 September 2023. https://www.census.gov/programs-surveys/nsch/data/datasets.html.
Office of Disease Prevention and Health Promotion. US Department of Health and Human Services. Healthy People 2030. Increase the proportion of children and adolescents with ADHD who get appropriate treatment, accessed 8 July 2024. https://health.gov/healthypeople/objectives-and-data/browse-objectives/children/increase-proportion-children-and-adolescents-adhd-who-get-appropriate-treatment-emc-04.
Acknowledgements
The NSCH team and all participants involved in our study are acknowledged.
Author information
Authors and Affiliations
Contributions
C.W. and Y.Z. conceived this study. C.W. and G.D. drafted the manuscript. Y.Z. supervised the work and, together with A.V., conducted the literature review, revised the data, and critically reviewed the manuscript text for important intellectual content prior to publication. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval and consent to participate
Because publicly available anonymized data were used, the institutional review board of Xinhua Hospital, Shanghai Jiao Tong University School of Medicine deemed this study exempt from review.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wen, C., Ding, G., Vinturache, A. et al. Adherence to clinical practice guideline for attention-deficit/hyperactivity disorder treatment among children and adolescents. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04197-5
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41390-025-04197-5
